Do inflammasome impact COVID-19 severity?

Volume: 32, Issue: 3, Pages: 410 - 420
Published: Jul 26, 2021
Abstract
COVID-19 pandemic has proven to be a dramatic challenge, introducing huge clinical differences that demand extensive investigations. Severe and critical patients may present coagulopathies and microthrombi, which results in varied complications, or acute respiratory distress syndrome that leads to fatality. Although the lung to be the major site of clinical manifestations, COVID-19 has shown extrapulmonary manifestations, especially on the heart...
Paper Details
Title
Do inflammasome impact COVID-19 severity?
Published Date
Jul 26, 2021
Volume
32
Issue
3
Pages
410 - 420
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.